| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07393659 A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or… |
Recruitment opened |
| 2026-08-15 | NCT07393659 A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or… |
Trial sites expanded: 0 -> 4 locations |
| 2026-08-15 | NCT07393659 A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or… |
date change Primary completion pushed: 2030-12-30 -> 2032-09-14 |
| 2026-08-15 | NCT07393659 A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or… |
date change Completion pushed: 2030-12-30 -> 2032-09-14 |
| 2026-08-15 | NCT07650916 A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra… |
Trial sites expanded: 54 -> 88 locations |
| 2026-08-06 | NCT06012136 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Suspension… |
Trial completed |
| 2026-08-04 | NCT07650916 A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra… |
Recruitment opened |
| 2026-08-04 | NCT07650916 A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra… |
Trial sites expanded: 0 -> 54 locations |
| 2026-07-31 | NCT02938520 Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular… |
Trial sites expanded: 44 -> 108 locations |
| 2026-07-31 | NCT06134362 Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure… |
Enrollment closed, study ongoing |
| 2026-07-31 | NCT06134362 Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure… |
Enrollment reduced: 3508 -> 2996 participants |
| 2026-07-31 | NCT06134362 Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure… |
date change Primary completion pushed: 2029-01-01 -> 2029-03-14 |
| 2026-07-31 | NCT06134362 Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure… |
date change Completion pushed: 2029-01-01 -> 2029-03-14 |
| 2026-07-30 | NCT06694805 A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) +… |
date change Completion moved earlier: 2028-08-28 -> 2028-06-08 |
| 2026-07-24 | NCT07202546 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1… |
Enrollment increased: 150 -> 186 participants |
| 2026-07-24 | NCT07202546 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1… |
Trial sites expanded: 113 -> 123 locations |
| 2026-07-24 | NCT07202546 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1… |
date change Primary completion moved earlier: 2027-07-26 -> 2027-06-11 |
| 2026-07-24 | NCT07202546 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1… |
date change Completion moved earlier: 2028-07-24 -> 2028-05-22 |
| 2026-07-23 | NCT06694805 A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) +… |
overall status: Recruiting → Active, Not Recruiting |
| 2026-07-23 | NCT06694805 A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) +… |
Trial sites reduced: 89 -> 85 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07393659 | A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or… | HIV Infections | Recruiting |
| NCT07650916 | A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra… | HIV Infections | Recruiting |
| NCT03299049 | Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting… | HIV Infections | Active, Not Recruiting |
| NCT02362503 | Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients | HIV Infections | Active, Not Recruiting |
| NCT05979311 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2… | HIV | Active, Not Recruiting |
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting… | Infection, Human Immunodeficiency Virus | Active, Not Recruiting |
| NCT06694805 | A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) +… | HIV Infections | Active, Not Recruiting |
| NCT02938520 | Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular… | HIV Infections | Active, Not Recruiting |
| NCT06134362 | Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure… | HIV Infections | Active, Not Recruiting |
| Phase 2 | |||
| NCT07202546 | A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1… | HIV Infections | Recruiting |
| NCT06741397 | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation… | HIV Infections | Active, Not Recruiting |
| NCT05996471 | A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir… | HIV Infections | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05674656 | Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics | HIV Infections | Recruiting |
| NCT07275606 | A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 | HIV Infections | Recruiting |
| Phase 1 | |||
| NCT06724640 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to… | HIV Infections | Recruiting |
| NCT05418868 | A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting… | HIV Infections | Recruiting |
| NCT07636928 | Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 | HIV Infections | Recruiting |
| NCT07525544 | A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants | HIV Infections | Recruiting |
| NCT06310551 | First Time in Human Study of Long Acting VH4524184 Formulations | HIV Infections | Recruiting |
| NCT06786520 | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra… | HIV Infections | Active, Not Recruiting |
| NCT06970223 | A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections… | HIV Infections | Active, Not Recruiting |
| NCT06652958 | A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody… | HIV Infections | Active, Not Recruiting |
| NCT07053384 | A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce… | HIV Infections | Active, Not Recruiting |